Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.0B | 10.6B | 8.9B | 8.2B |
| Cost of revenue | 6.6B | 8.4B | 7.8B | 6.5B |
| Gross profit | 1.5B | 2.1B | 1.1B | 1.7B |
| Operating expense | ||||
| Research & development | 239M | 265M | 243M | 237M |
| Selling general and admin | 1.2B | 1.3B | 1.2B | 938M |
| Other operating expenses | — | — | — | — |
| Operating income | 43M | 592M | -360M | 527M |
| Non operating interest income | ||||
| Income | 72M | 104M | 57M | 81M |
| Expense | — | — | — | — |
| Other income expense | 218M | 417M | 180M | 994M |
| Pretax income | 332M | 1.1B | -122M | 1.6B |
| Tax provision | 68M | 629M | -23M | 322M |
| Net income | 264M | 484M | -99M | 1.3B |
| Basic EPS | 0.9 | 1.8 | -0.4 | 4.7 |
| Diluted EPS | 0.9 | 1.7 | -0.4 | 4.7 |
| Basic average shares | 275M | 276M | 275M | 274M |
| Diluted average shares | 279M | 280M | 275M | 278M |
| EBITDA | 225M | 861M | 24M | -64M |
| Net income from continuing op. | 264M | 484M | -99M | 1.3B |
| Minority interests | -11M | 0 | 3M | 14M |
| Preferred stock dividends | — | — | — | — |